Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

FENC

Fennec Pharmaceuticals Inc

Apr 19 • 11:32AM ET

9.35

Dollar change -0.22
Percentage change -2.25	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM IWN VTWO IWC IWO VTWV RYLD VTWG BTEC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.60	Insider Own	17.44%	Shs Outstand	27.03M	Perf Week	-10.82%
Market Cap	253.52M	Forward P/E	9.57	EPS next Y	0.98	Insider Trans	-6.14%	Shs Float	22.37M	Perf Month	-15.49%
Income	-16.05M	PEG	-	EPS next Q	-0.06	Inst Own	56.00%	Short Float	8.11%	Perf Quarter	-6.54%
Sales	21.25M	P/S	11.93	EPS this Y	138.67%	Inst Trans	0.73%	Short Ratio	14.94	Perf Half Y	37.17%
Book/sh	-0.43	P/B	-	EPS next Y	321.55%	ROA	-59.64%	Short Interest	1.81M	Perf Year	15.92%
Cash/sh	0.49	P/C	19.10	EPS next 5Y	-	ROE	-1005.59%	52W Range	6.30 - 11.92	Perf YTD	-16.62%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-2.95%	ROI	-88.69%	52W High	-21.52%	Beta	0.45
Dividend TTM	-	Quick Ratio	3.27	Sales past 5Y	236.90%	Gross Margin	94.08%	52W Low	48.49%	ATR (14)	0.47
Dividend Ex-Date	-	Current Ratio	3.56	EPS Y/Y TTM	33.41%	Oper. Margin	-60.09%	RSI (14)	31.35	Volatility	4.77% 4.35%
Employees	29	Debt/Eq	-	Sales Y/Y TTM	1284.50%	Profit Margin	-75.50%	Recom	1.17	Target Price	17.37
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	61.59%	Payout	-	Rel Volume	0.86	Prev Close	9.57
Sales Surprise	12.35%	EPS Surprise	-455.56%	Sales Q/Q	534.20%	Earnings	Mar 26 BMO	Avg Volume	121.36K	Price	9.35
SMA20	-12.46%	SMA50	-7.26%	SMA200	4.74%	Trades		Volume	37,393	Change	-2.25%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-22-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$9 → $12
Sep-07-22	Initiated	CapitalOne	Overweight	$11
Aug-08-22	Resumed	Craig Hallum	Buy	$14
Jun-05-20	Initiated	Cantor Fitzgerald	Overweight	$18
Oct-11-18	Initiated	Goldman	Buy

Apr-05-24 07:00PM	Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-27-24 07:00PM	Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-26-24 01:00AM	Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-22-24 09:49AM	Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:04AM	Q4 2023 Fennec Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
02:52PM	Loading…
Mar-21-24 02:52PM	FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
06:00AM	Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-19-24 10:14AM	Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up (Zacks)
06:01AM	Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024 (GlobeNewswire)
Mar-17-24 09:00PM	Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand (GlobeNewswire)
Feb-29-24 07:04AM	Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Feb-01-24 05:55AM	FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin (GlobeNewswire)
Jan-06-24 03:01AM	Insider Sell: CFO Robert Andrade Sells 30,000 Shares of Fennec Pharmaceuticals Inc (GuruFocus.com)
Dec-05-23 05:55AM	Fennec Announces Incremental $5 Million Investment from Petrichor (GlobeNewswire)
Nov-09-23 04:50PM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
09:40AM	Loading…
Nov-07-23 09:40AM	Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript (Insider Monkey)
02:10AM	Q3 2023 Fennec Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 05:59AM	Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +15.36%
Oct-30-23 06:45AM	Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023 (GlobeNewswire)
Sep-07-23 05:59AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-10-23 12:53PM	Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-03-23 05:59AM	Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) -7.29%
Jul-31-23 05:30AM	Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023 (GlobeNewswire) +8.66%
Jun-12-23 05:00PM	Fennec Announces Results of Annual Meeting (GlobeNewswire)
Jun-08-23 02:53PM	Retail investors who hold 38% of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) gained 13%, institutions profited as well (Simply Wall St.)
Jun-06-23 05:44AM	Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients (GlobeNewswire)
May-11-23 06:01AM	Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-08-23 06:15AM	Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023 (GlobeNewswire)
Apr-28-23 09:26AM	When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Become Profitable? (Simply Wall St.)
Apr-01-23 08:12AM	Investors in Fennec Pharmaceuticals (NASDAQ:FENC) have made a notable return of 52% over the past three years (Simply Wall St.)
08:03AM	Loading…
Mar-31-23 08:03AM	Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients (GlobeNewswire)
Mar-30-23 05:55AM	Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results (GlobeNewswire)
Mar-24-23 06:30AM	7 Biotech Stocks Sitting in the Sweet Spot (InvestorPlace)
Feb-23-23 08:44AM	Why Earnings Season Could Be Great for Adherex Technologies (FENC) (Zacks)
Jan-31-23 06:00AM	Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA (GlobeNewswire) +6.26%
Jan-25-23 07:19AM	Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients (GlobeNewswire) +8.27%
Jan-23-23 11:57AM	RTP drugmaker Fennec sues Cipla over generics effort (American City Business Journals)
Dec-17-22 09:55AM	Institutions own 28% of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) shares but individual investors control 55% of the company (Simply Wall St.)
Nov-11-22 07:10AM	Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Nov-01-22 10:28AM	Fennec Pharmaceuticals Inc. (NASDAQ:FENC): Are Analysts Optimistic? (Simply Wall St.)
Oct-17-22 08:00AM	Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States (GlobeNewswire)
Sep-26-22 07:35AM	Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor (GlobeNewswire) -8.30%
Sep-21-22 02:19PM	RTP pharma to see $20M infusion on heels of drug winning approval (American City Business Journals) +11.93%
01:05PM	After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss (Benzinga)
07:00AM	Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection) (GlobeNewswire)
06:05AM	U.S. FDA approves Fennec's hearing loss therapy (Reuters)
Aug-22-22 07:04AM	Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor (GlobeNewswire)
Aug-12-22 06:59AM	Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-22 02:59PM	RTP drugmaker secures up to $45M despite regulatory speed bumps (American City Business Journals)
07:30AM	Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor (GlobeNewswire)
Jul-10-22 08:42AM	What Kind Of Shareholders Own Fennec Pharmaceuticals Inc. (NASDAQ:FENC)? (Simply Wall St.)
Jun-14-22 06:00PM	Fennec Announces Results of Annual Meeting (GlobeNewswire)
May-23-22 07:29AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-22 06:00AM	Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-06-22 05:17PM	Inflation crushes market caps of Triangle's biggest public companies except these ones (American City Business Journals)
May-03-22 09:55AM	Can Adherex Technologies Inc. (FENC) Climb 92% to Reach the Level Wall Street Analysts Expect? (Zacks)
Apr-27-22 06:00AM	Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK (GlobeNewswire) -9.27%
Mar-25-22 07:00AM	Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference (GlobeNewswire)
Mar-24-22 06:00AM	Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark (GlobeNewswire) -6.41%
Feb-28-22 06:00AM	Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update (GlobeNewswire)
Jan-31-22 06:00AM	Fennec Pharmaceuticals Announces Management Change (GlobeNewswire) +5.20%
Jan-27-22 05:38PM	Hartford Financial Management Inc. Buys Exelon Corp, American Electric Power Co Inc, Pinnacle ... (GuruFocus.com) -7.54%
Dec-14-21 07:50PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC (ACCESSWIRE)
Dec-13-21 10:08AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC (PR Newswire)
Dec-01-21 07:06AM	RTP drugmaker suffers another regulatory setback (American City Business Journals) -11.39%
Nov-30-21 04:20PM	Fennec (FENC) Gets CRL From FDA for Pedmark, Stock Down (Zacks) -8.16%
10:57AM	FENC Fennec Pharmaceuticals Inc. Investors Who Have Lost More Than $25,000 Are Encouraged To Contact Kehoe Law Firm, P.C. Securities Class Action Investigation (GlobeNewswire)
06:00AM	Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors (GlobeNewswire)
05:49AM	When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Breakeven? (Simply Wall St.)
Nov-29-21 07:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC (GlobeNewswire) -50.41%
07:24AM	Fennec Pharmaceuticals Expects FDA Rejection for New Drug (Investing.com)
06:00AM	Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors (GlobeNewswire)
Nov-10-21 06:00AM	Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)
Oct-05-21 08:30AM	4 Breakout Stocks for Impressive Returns (Zacks)
Sep-29-21 02:27PM	Hedge Funds Are Piling Into Fennec Pharmaceuticals Inc. (FENC) (Insider Monkey)
Sep-09-21 06:00AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-10-21 06:00AM	Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)
Aug-02-21 03:18AM	Is Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Popular Amongst Institutions? (Simply Wall St.)
Jun-29-21 05:30PM	Fennec Announces Results of Annual Meeting (GlobeNewswire)
Jun-24-21 06:00AM	Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility (GlobeNewswire) +7.52%
Jun-22-21 07:17AM	Fennec Pharma Stock Is Trading Higher As Pedmark Is Under FDA Review For Chemo-Induced Toxicity (Benzinga) +5.13%
06:00AM	Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for PEDMARK (GlobeNewswire)
Jun-03-21 03:33AM	Here's Why We're Not Too Worried About Fennec Pharmaceuticals' (NASDAQ:FENC) Cash Burn Situation (Simply Wall St.)
May-28-21 06:00AM	Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for PEDMARK (GlobeNewswire) +6.66%
May-13-21 06:00AM	Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)
Apr-04-21 05:54AM	Analysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (Simply Wall St.)
Mar-30-21 06:00AM	Fennec Announces Fiscal Year 2020 Financial Results and Provides Business Update (GlobeNewswire)
Feb-03-21 01:59AM	What Type Of Shareholders Make Up Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) Share Registry? (Simply Wall St.)
Dec-09-20 07:51AM	New Strong Sell Stocks for December 9th (Zacks) -5.74%
Dec-02-20 11:27PM	Here is What Hedge Funds Think About Fennec Pharmaceuticals Inc. (FENC) (Insider Monkey)
Nov-27-20 10:27AM	New Strong Sell Stocks for November 27th (Zacks)
Nov-19-20 10:02AM	New Strong Sell Stocks for November 19th (Zacks)
Nov-16-20 07:02AM	Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update (GlobeNewswire)
Nov-05-20 07:46AM	Here's Why We're Not Too Worried About Fennec Pharmaceuticals' (NASDAQ:FENC) Cash Burn Situation (Simply Wall St.)
Nov-02-20 03:57PM	FENC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 2, 2020 in the Class Action Filed on Behalf of Fennec Pharmaceuticals Inc. Limited Shareholders (Newsfile)
02:30PM	FENC Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020 (ACCESSWIRE)
01:10PM	LAWSUITS FILED AGAINST POR, FENC and CLNC - Jakubowitz Law Pursues Shareholders Claims (ACCESSWIRE)
11:29AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 2, 2020 - FENC (Newsfile)
10:00AM	FENC Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020 (Newsfile)
09:15AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of POR, FENC and NKLA (ACCESSWIRE)

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 18 '24	Sale	9.62	22,222	213,776	0	Apr 18 09:43 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 17 '24	Sale	9.91	22,222	220,220	22,222	Apr 18 09:43 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 16 '24	Sale	10.28	22,222	228,389	0	Apr 16 06:00 PM
RALLIS CHRIS A	Director	Apr 15 '24	Option Exercise	10.45	1,389	14,515	45,838	Apr 15 06:15 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 15 '24	Sale	10.30	22,222	228,793	22,222	Apr 16 06:00 PM
RALLIS CHRIS A	Director	Apr 15 '24	Sale	10.45	800	8,360	44,449	Apr 15 06:15 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Apr 05 '24	Sale	10.75	44,300	476,269	187,471	Apr 05 04:56 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Apr 04 '24	Sale	10.89	44,283	482,400	231,771	Apr 05 04:56 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Apr 03 '24	Sale	10.78	40,584	437,451	276,054	Apr 03 05:37 PM
RALLIS CHRIS A	Director	Mar 26 '24	Option Exercise	2.31	4,329	10,000	45,249	Mar 27 04:24 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Mar 26 '24	Sale	10.90	13,975	152,346	91,771	Mar 27 04:22 PM
RALLIS CHRIS A	Director	Mar 26 '24	Sale	10.97	2,114	23,191	40,920	Mar 27 04:24 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Mar 25 '24	Sale	11.00	13,975	153,690	105,746	Mar 25 07:31 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Jan 05 '24	Sale	10.41	15,000	156,150	119,721	Jan 05 05:24 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Jan 04 '24	Sale	10.64	15,000	159,600	134,721	Jan 05 05:24 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Dec 28 '23	Option Exercise	1.59	8,540	13,579	291,127	Dec 29 04:30 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Dec 28 '23	Sale	11.55	3,656	42,227	287,471	Dec 29 04:30 PM
RALLIS CHRIS A	Director	Dec 26 '23	Option Exercise	1.59	3,144	4,999	46,178	Dec 28 04:02 PM
RALLIS CHRIS A	Director	Dec 26 '23	Sale	10.90	1,390	15,151	44,788	Dec 28 04:02 PM
RALLIS CHRIS A	Director	Nov 20 '23	Sale	8.25	269	2,219	43,034	Nov 20 09:20 PM
Islam Khalid	Director	Nov 16 '23	Option Exercise	2.06	213,825	441,400	213,825	Nov 16 04:05 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Nov 08 '23	Sale	7.76	25,044	194,267	282,587	Nov 09 04:38 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Nov 03 '23	Option Exercise	1.59	74,793	118,921	307,631	Nov 03 05:19 PM
RALLIS CHRIS A	Director	Aug 18 '23	Sale	7.85	673	5,283	43,303	Aug 18 05:00 PM
RALLIS CHRIS A	Director	Jul 24 '23	Option Exercise	0.72	16,666	12,000	50,772	Jul 24 05:04 PM
RALLIS CHRIS A	Director	Jul 24 '23	Sale	8.17	6,796	55,523	43,976	Jul 24 05:04 PM
RALLIS CHRIS A	Director	Jul 06 '23	Option Exercise	0.96	5,280	5,069	34,106	Jul 06 05:20 PM
RALLIS CHRIS A	Director	Jul 06 '23	Sale	8.47	2,207	18,693	28,826	Jul 06 05:20 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Jun 30 '23	Option Exercise	2.45	25,000	61,250	149,721	Jun 30 04:21 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Jun 30 '23	Sale	8.82	7,500	66,150	124,721	Jun 30 04:21 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Jun 29 '23	Sale	8.97	7,500	67,275	132,221	Jun 30 04:21 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Jun 28 '23	Sale	8.99	10,000	89,900	139,721	Jun 30 04:21 PM
RALLIS CHRIS A	Director	May 19 '23	Sale	7.36	1,758	12,939	31,033	May 19 04:41 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FENC

Fennec Pharmaceuticals Inc

Upgrade your FINVIZ experience